{
  "id": 5355,
  "text": "Available at: http://www.ncbi.nlm.nih.gov/pubmed/21629215.174.Duenas-Gonzalez A, Zarba JJ, Patel F, et al.Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Available at: http://www.ncbi.nlm.nih.gov/pubmed/21629215.174.Duenas-Gonzalez A, Zarba JJ, Patel F, et al.Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "关于宫颈癌IIIB期到IVA期患者的治疗方法，有研究比较了两种治疗方案：同步顺铂与放疗，对比同步吉西他滨、顺铂加放疗及后续辅助使用吉西他滨和顺铂的效果。研究表明，同步使用吉西他滨和顺铂加上放疗，并在治疗后期辅以吉西他滨和顺铂，可能在某些方面提供了优势，但具体的疗效和安全性需要根据患者的具体情况来考虑，且需要进一步的临床试验验证。选择最适合的治疗方案应根据详细的病理检查和患者的身体状况进行综合评估，并与医疗团队进行深入讨论。",
  "query": "关于宫颈癌的IIIB期到IVA期患者，是否有研究比较同步顺铂和放疗与同步吉西他滨、顺铂加放疗及后续辅助吉西他滨和顺铂的治疗效果？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 关于宫颈癌的IIIB期到IVA期患者，是否有研究比较同步顺铂和放疗与同步吉西他滨、顺铂加放疗及后续辅助吉西他滨和顺铂的治疗效果？\n\n<reference text>: Available at: http://www.ncbi.nlm.nih.gov/pubmed/21629215.174.Duenas-Gonzalez A, Zarba JJ, Patel F, et al.Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "关于宫颈癌IIIB期到IVA期患者的治疗方法，有研究比较了两种治疗方案：同步顺铂与放疗，对比同步吉西他滨、顺铂加放疗及后续辅助使用吉西他滨和顺铂的效果。研究表明，同步使用吉西他滨和顺铂加上放疗，并在治疗后期辅以吉西他滨和顺铂，可能在某些方面提供了优势，但具体的疗效和安全性需要根据患者的具体情况来考虑，且需要进一步的临床试验验证。选择最适合的治疗方案应根据详细的病理检查和患者的身体状况进行综合评估，并与医疗团队进行深入讨论。"
}